While many of the patients that come through the UCSF Fresno Cystic Fibrosis Center are still young, they have transitioned ...

Investigators have developed STITCHR, a new gene editing tool that can insert therapeutic genes into specific locations without causing unwanted mutations. The system can be formulated completely as ...

CRISPR-Cas9 gene editing technology has emerged as one of the most transformative advancements in medicine and biotechnology.

They were told they’d die young. Then a ‘miracle drug’ changed everything — and they have to grapple with what that means - ...

Ryan Hunter, PhD, associate professor of microbiology and immunology, recently created a device to study anaerobic bacteria alongside oxygenated cells, simulating microenvironments within the body.

They then sought permission from the United Kingdom’s Human Fertilisation and Embryology Authority to create a saviour ...

Cysts, fibrosis, and tubular degeneration form the typical triad of pathologies leading to the gradual decline in kidney ...

A new method enables anti-inflammatory drugs to cross the blood-brain barrier, offering hope for treating brain-related ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicine company focused on the development of infectious disease vaccines and opportunities ...